Nicole Pezzino, PharmD, BCACP, BC-ADM, CDCES, details how pharmacies can utilize the booming GLP-1 medication class for greater revenue opportunities.
|Slideshows|October 1, 2018
- Drug Topics January 2019
- Volume 163
- Issue 1
The 10 Apps Pharmacists Should Be Using
Author(s)Nicholas Hamm
From productivity to relaxation, these apps can help you be better at everything you do.
Advertisement
Articles in this issue
over 7 years ago
How Blockchain Can Reduce Waste, Fraud in Pharmacyover 7 years ago
A Pharmacist's New Year's Resolutionsover 7 years ago
Duvelisib for Relapsed or Refractory CLL/SLLover 7 years ago
Opinion: A New Toolkit to Fight Opioid Abusealmost 8 years ago
10 Pharmacists to Follow on Twitteralmost 8 years ago
Small Doses: January Newsalmost 8 years ago
The 10 Most Exciting Drugs in the 2019 Pipelinealmost 8 years ago
Pharmacist-Driven Intervention Program Reduces Readmissionsalmost 8 years ago
Chronic Kidney Disease Patients Need Advice On Diet, Drug Buildupalmost 8 years ago
Independent Pharmacies: Not Dead YetAdvertisement
Related to this article
Matt Martin, PharmD, BCSCP, explores current developments in the peptide space and what pharmacists need to know amid FDA decision-making processes.
This new, nonprescription therapy expands eye relief options for patients in need of apraclonidine eye drop formulations.
Cheri Schmit explains how pharmacists' roles are growing beyond dispensing into prevention, test-and-treat, and artificial intelligence-supported patient care.
In celebration of American Pharmacists Month, Melissa McGivney, PharmD, FAPhA, FCCP, provides a snapshot of where the profession has come and where it still has to go.
Pharmacist-backed picks help families manage fever and pain, seasonal allergies, and cough and congestion as kids head back to the classroom.
Sara Hover, RPh, FAARM, explains how these products are putting pharmacists at the center of safety and evidence evaluations one patient at a time.
Independent pharmacies adapt to specialty drugs, biosimilars, cold-chain, and REMS demands.
Advertisement
Advertisement